{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:19:25Z","timestamp":1785453565975,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Hintergrund<\/jats:title>\n                    <jats:p>In Deutschland wurden 2026 Qualit\u00e4tsindikatoren des Instituts f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (IQTIG) zu Diagnostik und Therapie der Sepsis in Krankenh\u00e4usern verpflichtend eingef\u00fchrt. Bisher existieren kaum Daten, inwiefern Qualit\u00e4tsindikatoren in Form von Ma\u00dfnahmen zu Sepsiserkennung und -therapie bereits etabliert sind.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methode<\/jats:title>\n                    <jats:p>Sekund\u00e4ranalyse des European Sepsis Care Survey, einer internationalen Querschnittstudie zu Strukturen der Sepsisversorgung in Akutkrankenh\u00e4usern. In Deutschland wurden leitende \u00c4rzte aus Krankenh\u00e4usern aller Bundesl\u00e4nder und aller Versorgungsstufen systematisch zur Teilnahme eingeladen. Die Analyse erfolgte in Bezug auf 7 Qualit\u00e4tsindikatoren des IQTIG zu Diagnostik und Therapie der Sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>\n                      In Deutschland wurden 253 Krankenh\u00e4user (20\u202f% aller Akutkrankenh\u00e4user) analysiert. Ein standardisiertes Screening zur Fr\u00fcherkennung einer Sepsis existierte krankenhausweit in 34,8\u202f% (95%-KI:27,9\u201342,3\u202f%), standardisierte Ma\u00dfnahmen zum Sepsismanagement in 36,6\u202f% (95%-KI 29,2\u201344,5\u202f%) der Krankenh\u00e4user. Dabei bestanden Unterschiede zwischen Notaufnahmen, Normalstationen und Intensivstationen (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&lt;\u20090,05), aber keine signifikanten Unterschiede zwischen universit\u00e4ren und nichtuniversit\u00e4ren Krankenh\u00e4usern. Regelm\u00e4\u00dfige Schulungen des \u00e4rztlichen und pflegerischen Dienstes aller Abteilungen existierten in 4,7\u202f% (95%-KI:2,3\u20138,5\u202f%) der Krankenh\u00e4user.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Schlussfolgerung<\/jats:title>\n                    <jats:p>In Deutschland existierten krankenhausweite standardisierte Ma\u00dfnahmen zu Fr\u00fcherkennung und Behandlung einer Sepsis nur in wenigen Krankenh\u00e4usern. Regelm\u00e4\u00dfige Schulungen des \u00e4rztlichen und pflegerischen Personals zur Qualit\u00e4tsverbesserung wurden kaum durchgef\u00fchrt. Vor diesem Hintergrund ist die Etablierung von qualit\u00e4tsverbessernden Programmen dringend geboten, bedarf aber gleichzeitig klarer Strukturen und ausreichender Ressourcen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00101-026-01663-5","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:52:08Z","timestamp":1773913928000},"page":"333-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sepsisversorgung in Deutschland: Qualit\u00e4tsindikatoren zu Diagnostik und Therapie der Sepsis","Sepsis care in Germany: quality indicators on diagnostics and treatment of sepsis"],"prefix":"10.1007","volume":"75","author":[{"given":"Christian S.","family":"Scheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny A.","family":"Idelevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Oelsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Packmohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gr\u00fcndling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"11","key":"1663_CR1","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1007\/s00134-018-5377-4","volume":"44","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek\u00a0C, Mikolajetz\u00a0A, Schwarzkopf\u00a0D, Cohen\u00a0J, Hartog\u00a0CS, Pletz\u00a0M et\u00a0al (2018) Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany. Intensive Care Med 44(11):1826\u20131835","journal-title":"Intensive Care Med"},{"issue":"11","key":"1663_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34290","volume":"4","author":"C Fleischmann-Struzek","year":"2021","unstructured":"Fleischmann-Struzek\u00a0C, Rose\u00a0N, Freytag\u00a0A, Spoden\u00a0M, Prescott\u00a0HC, Schettler\u00a0A et\u00a0al (2021) Epidemiology and Costs of Postsepsis Morbidity, Nursing Care Dependency, and Mortality in Germany, 2013 to 2017. JAMA Netw Open 4(11):e2134290","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1663_CR3","first-page":"159","volume":"113","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann\u00a0C, Thomas-Rueddel\u00a0DO, Hartmann\u00a0M, Hartog\u00a0CS, Welte\u00a0T, Heublein\u00a0S et\u00a0al (2016) Hospital incidence and mortality rates of sepsis\u2014an analysis of hospital episode (DRG) statistics in Germany from 2007 to 2013. Dtsch Arztebl Int 113(10):159\u2013166","journal-title":"Dtsch Arztebl Int"},{"issue":"46","key":"1663_CR4","first-page":"775","volume":"117","author":"K Schmidt","year":"2020","unstructured":"Schmidt\u00a0K, Gensichen\u00a0J, Fleischmann-Struzek\u00a0C, Bahr\u00a0V, Pausch\u00a0C, Sakr\u00a0Y et\u00a0al (2020) Long-term survival following sepsis\u2014results of a single-center registry study with four year follow-up. Dtsch Arztebl Int 117(46):775\u2013782","journal-title":"Dtsch Arztebl Int"},{"key":"1663_CR5","unstructured":"Fleischmann-Struzek C, Spoden M, Dr\u00f6ge P, Freytag A, Ditscheid B, Schlattmann P et\u00a0al (2022) \u201eSEPFROK \u2013 Sepsis: Folgeerkrankungen, Risikofaktoren, Versorgung und Kosten\u201c Ergebnisbericht. Gemeinsamer Bundesausschuss. 2022;Innovationsausschuss."},{"issue":"11","key":"1663_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W, Antonelli\u00a0M, Coopersmith\u00a0CM, French\u00a0C et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247","journal-title":"Intensive Care Med"},{"key":"1663_CR7","unstructured":"Brunkhorst FM, WM WM, Pletz M, Gastmeier P, Lemmen SW, Meier-Hellmann A, Ragaller M, Weyland A, Marx G, Bucher M, Gerlach H, Salzberger B, Grabein B, Welte T, Werdan K, Kluge S, Bone HG, Putensen Ch, Rossaint R, Quintel M, Spies C, Wei\u00df B, John S, Oppert M, J\u00f6rres A, Brenner T, Elke G, Gr\u00fcndling M, Mayer K, Weimann A, Felbinger TW, Axer H (2018) S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge. AWMF. 2018;AWMF-Registernummer: 079 \u2013 001."},{"key":"1663_CR8","unstructured":"(2017) WHA 70.7 Resolution: Improving the prevention, diagnosis and clinical management of sepsis. https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA70\/A70_R7-en.pdf. Accessed .6.2022"},{"issue":"9","key":"1663_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00134-023-07127-3","volume":"49","author":"EJ Giamarellos-Bourboulis","year":"2023","unstructured":"Giamarellos-Bourboulis\u00a0EJ, Zinkernagel\u00a0AS, De Robertis\u00a0E, Azoulay\u00a0E, De Luca\u00a0D (2023) Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control. Intensive Care Med 49(9):1138\u20131142","journal-title":"Intensive Care Med"},{"key":"1663_CR10","unstructured":"Gemeinsamer Bundesausschuss (2020) Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine Beauftragung des IQTIG mit der Entwicklung eines Qualit\u00e4tssicherungsverfahrens Diagnostik, Therapie und Nachsorge der Sepsis."},{"key":"1663_CR11","unstructured":"Bundesausschuss G (2020) Sepsis: G\u2011BA beauftragt IQTIG mit Entwicklung eines QS-Verfahrens."},{"key":"1663_CR12","unstructured":"Bundesausschuss G (2024) Diagnostik und Therapie von Sepsis: G\u2011BA erm\u00f6glicht Qualit\u00e4tsvergleich von Krankenh\u00e4usern g\u2011ba website: Gemeinsamer Bundesausschuss; Berlin. https:\/\/www.g-ba.de\/presse\/pressemitteilungen-meldungen\/1230\/"},{"key":"1663_CR13","unstructured":"IQTIG \u2013 Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (2023) Qualit\u00e4tssicherungsverfahren \u201eDiagnostik, Therapie und Nachsorge der Sepsis\u201c Machbarkeitspr\u00fcfung Abschlussbericht."},{"key":"1663_CR14","unstructured":"IQTIG \u2013 Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (2023) Qualit\u00e4tssicherungsverfahren \u201eDiagnostik, Therapie und Nachsorge der Sepsis\u201c Machbarkeitspr\u00fcfung Anhang."},{"key":"1663_CR15","unstructured":"IQTIG \u2013 Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (2024) Qualit\u00e4tssicherungsverfahren \u201eDiagnostik, Therapie und Nachsorge der Sepsis\u201c Machbarkeitspr\u00fcfung Abschlussbericht Indikatorenset V2\u20111."},{"issue":"4","key":"1663_CR16","first-page":"587","volume":"211","author":"CS Scheer","year":"2025","unstructured":"Scheer\u00a0CS, Giamarellos-Bourboulis\u00a0EJ, Ferrer\u00a0R, Idelevich\u00a0EA, Annane\u00a0D, Artigas\u00a0A et\u00a0al (2025) Status of sepsis care in European hospitals: Results from an international cross-sectional survey. AJRCCM 211(4):587\u2013599","journal-title":"AJRCCM"},{"issue":"11","key":"1663_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos\u00a0F, Ruddel\u00a0H, Thomas-Ruddel\u00a0D, Schwarzkopf\u00a0D, Pausch\u00a0C, Harbarth\u00a0S et\u00a0al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602\u20131612","journal-title":"Intensive Care Med"},{"key":"1663_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos\u00a0F, Thomas-R\u00fcddel\u00a0D, R\u00fcddel\u00a0H, Engel\u00a0C, Schwarzkopf\u00a0D, Marshall\u00a0JC et\u00a0al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Critical Care 18:R42","journal-title":"Critical Care"},{"key":"1663_CR19","unstructured":"https:\/\/www.deutsches-krankenhaus-verzeichnis.de [Internet]. [cited 20.12.2024]. Available from:."},{"issue":"17","key":"1663_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2023.16693","volume":"330","author":"HC Prescott","year":"2023","unstructured":"Prescott\u00a0HC, Posa\u00a0PJ, Dantes\u00a0R (2023) The Centers for Disease Control and Prevention\u2019s Hospital Sepsis Program Core Elements. JAMA 330(17):1617\u20131618","journal-title":"JAMA"},{"key":"1663_CR21","volume-title":"Hospital Sepsis Program Core Elements:2023","author":"Centers for Disease CaPC","year":"2023","unstructured":"Centers for Disease CaPC (2023) Hospital Sepsis Program Core Elements:2023. US Department of Health and Human Services, CDC, Atlanta, GA"},{"key":"1663_CR22","volume-title":"Hospital Sepsis Management and Practices: Findings from the 2023 NHSN Annual Survey","author":"Centers for Disease CaPC","year":"2024","unstructured":"Centers for Disease CaPC (2024) Hospital Sepsis Management and Practices: Findings from the 2023 NHSN Annual Survey. US Department of Health and Human Services, CDC, Atlanta, GA"},{"key":"1663_CR23","doi-asserted-by":"crossref","unstructured":"Dantes RB, Kaur H, Bouwkamp BA, Haass KA, Patel P, Dudeck MA, et\u00a0al. Sepsis Program Activities in Acute Care Hospitals \u2014 National Healthcare Safety Network, United States, 2022. US Department of Health and Human Services | Centers for Disease Control and Prevention , MMWR. 2023;72(34).","DOI":"10.15585\/mmwr.mm7234a2"},{"issue":"1","key":"1663_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13049-017-0437-2","volume":"25","author":"N Roberts","year":"2017","unstructured":"Roberts\u00a0N, Hooper\u00a0G, Lorencatto\u00a0F, Storr\u00a0W, Spivey\u00a0M (2017) Barriers and facilitators towards implementing the Sepsis Six care bundle (BLISS-1): a mixed methods investigation using the theoretical domains framework. Scand J Trauma Resusc Emerg Med 25(1):96\u201396","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"4","key":"1663_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jcrc.2015.03.022","volume":"30","author":"CT Matthaeus-Kraemer","year":"2015","unstructured":"Matthaeus-Kraemer\u00a0CT, Thomas-Rueddel\u00a0DO, Schwarzkopf\u00a0D, Rueddel\u00a0H, Poidinger\u00a0B, Reinhart\u00a0K et\u00a0al (2015) Barriers and supportive conditions to improve quality of care for critically ill patients: A team approach to quality improvement. J\u00a0Crit Care 30(4):685\u2013691","journal-title":"J Crit Care"},{"key":"1663_CR26","doi-asserted-by":"crossref","unstructured":"Breen S\u2011J, Rees S. Barriers to implementing the Sepsis Six guidelines in an acute hospital setting. British Journal of Nursing. 2018;27(9).","DOI":"10.12968\/bjon.2018.27.9.473"},{"key":"1663_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.882340","volume":"9","author":"D Schwarzkopf","year":"2022","unstructured":"Schwarzkopf\u00a0D, Ruddel\u00a0H, Brinkmann\u00a0A, Fleischmann-Struzek\u00a0C, Friedrich\u00a0ME, Glas\u00a0M et\u00a0al (2022) The German Quality Network Sepsis: Evaluation of a Quality Collaborative on Decreasing Sepsis-Related Mortality in a Controlled Interrupted Time Series Analysis. Front Med (Lausanne) 9:882340","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1663_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07915-9","volume":"12","author":"D Schwarzkopf","year":"2022","unstructured":"Schwarzkopf\u00a0D, Matthaeus-Kraemer\u00a0CT, Thomas-Ruddel\u00a0DO, Ruddel\u00a0H, Poidinger\u00a0B, Bach\u00a0F et\u00a0al (2022) A multifaceted educational intervention improved anti-infectious measures but had no effect on mortality in patients with severe sepsis. Sci Rep 12(1):3925","journal-title":"Sci Rep"},{"issue":"3","key":"1663_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cmi.2018.05.016","volume":"25","author":"CS Scheer","year":"2019","unstructured":"Scheer\u00a0CS, Fuchs\u00a0C, Grundling\u00a0M, Vollmer\u00a0M, Bast\u00a0J, Bohnert\u00a0JA et\u00a0al (2019) Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect 25(3):326\u2013331","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1663_CR30","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul\u00a0M, Shani\u00a0V, Muchtar\u00a0E, Kariv\u00a0G, Robenshtok\u00a0E, Leibovici\u00a0L (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54(11):4851\u20134863","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1663_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri\u00a0SS, Lai\u00a0YL, Warner\u00a0S, Strich\u00a0JR, Babiker\u00a0A, Ricotta\u00a0EE et\u00a0al (2021) Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis 21(2):241\u2013251","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1663_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00134-019-05871-z","volume":"46","author":"JJ De Waele","year":"2020","unstructured":"De Waele\u00a0JJ, Schouten\u00a0J, Beovic\u00a0B, Tabah\u00a0A, Leone\u00a0M (2020) Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions\u2011a viewpoint of experts. Intensive Care Med 46(2):236\u2013244","journal-title":"Intensive Care Med"},{"issue":"11","key":"1663_CR33","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cmi.2019.03.024","volume":"25","author":"EA Idelevich","year":"2019","unstructured":"Idelevich\u00a0EA, Seifert\u00a0H, Sundqvist\u00a0M, Scudeller\u00a0L, Amit\u00a0S, Balode\u00a0A et\u00a0al (2019) Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. Clin Microbiol Infect 25(11):1399\u20131407","journal-title":"Clin Microbiol Infect"},{"key":"1663_CR34","unstructured":"Notfallmedizin: Letalit\u00e4t bei Sepsis reduzieren . Dtsch \u00c4rztebl. 2024;121(4):A-251 \/ B\u201131."},{"issue":"15","key":"1663_CR35","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2217\/fmb-2018-0228","volume":"13","author":"JM Blondeau","year":"2018","unstructured":"Blondeau\u00a0JM, Idelevich\u00a0EA (2018) The 24\u2011h clinical microbiology service is essential for patient management. Future Microbiology 13(15):1625\u20131628","journal-title":"Future Microbiology"},{"key":"1663_CR36","unstructured":"M. Gr\u00fcndling, Dennler U. Die klinische Sicht: schnelle Erregerdiagnostik bei Sepsis. Management & Krankenhaus kompakt. 2024;1\u20112 22."},{"key":"1663_CR37","unstructured":"K. Becker, E. A. Idelevich, Rohde H. Medizinische Mikrobiologie: schnelle Erregerdiagnostik bei Sepsis . Management & Krankenhaus kompakt. 2024;1\u20112 23."},{"key":"1663_CR38","unstructured":"IQTIG \u2013 Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (2022) Entwicklung eines Qualit\u00e4tssicherungsverfahrens \u201eDiagnostik, Therapie und Nachsorge der Sepsis\u201c W\u00fcrdigung der Stellungnahmen zum Vorbericht."}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-026-01663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-026-01663-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-026-01663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:04:29Z","timestamp":1777467869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-026-01663-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s00101-026-01663-5","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.S.\u00a0Scheer gibt an von BD Unterst\u00fctzung f\u00fcr Reisekosten zu Meetings und Honorare als Sprecher erhalten zu haben. M.\u00a0Gr\u00fcndling gibt an im Rahmen des SepsisDialog Zusch\u00fcsse von #DeutschlendErkenntSepsis des German Federal Ministry of Health, sowie Honorare von Gradientech, BioMerieux, Pfizer, Shionogi, Sysmex, Becton Dickinson und Roche Diagnostics erhalten zu haben. Er ist au\u00dferdem Mitglied des Advisory Bord von InfectoGnostics, Jena, und Mitglied bei Deutschland Erkennt Sepsis. K.\u00a0Reinhart gibt an, Chairman der Sepsis Stiftung zu sein, und ist share holder von InflaRx N.V. Dieses Unternehmen hat eine Notfallzulassung durch die FDA sowie eine Zulassung durch die EMA f\u00fcr einen Antik\u00f6rper erhalten, der den Komplementfaktor C5a blockiert, da er COVID-19-bedingtes ARDS und Sepsis reduziert hat. E.A.\u00a0Idelevich gibt an, mehrere projektbezogene institutionelle Zusch\u00fcsse des Landes Mecklenburg-Vorpommern durch den European Regional Development Fund (ERDF), das German Federal Ministry of Education and Research (BMBF) und die MetaSystems Hard & Software GmbH erhalten zu haben. Sie gibt au\u00dferdem an, Erfinderverg\u00fctung f\u00fcr Patentlizenzen\u00a0\u2013 drei Patentanmeldungen, die von der Universit\u00e4t M\u00fcnster an Bruker lizenziert wurden, erhalten zu haben. Zus\u00e4tzlich erhielt sie Beratungshonorare vom Institute for Quality Assurance and Transparency in Health Care (IQTIG) f\u00fcr Expertent\u00e4tigkeit im Qualit\u00e4tssicherungsverfahren f\u00fcr Diagnose, Behandlung und Nachsorge von Sepsis; Vorlesungshonorare von Pfizer, BD und Shionogi, sowie Reiseunterst\u00fctzung von Bruker f\u00fcr das Symposium auf der ECCMID 2022 (Unterst\u00fctzung der Kongressreise). S.\u00a0Oelsner und J.\u00a0Packmohr geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr den European Sepsis Care Survey existieren eine Zustimmung der Ethikkommission der Universit\u00e4tsmedizin Greifswald (BB 124\/21) und eine Registrierung unter clinicaltrials.gov (Identifier: NCT05059808).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}